Feed / ADMA

ADMA Biologics, Inc.

ADMA

Healthcare · 9.73 +1.9% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

ADMA Biologics, Inc.'s current read is isolated; its market group is not confirming.

The latest filing evidence is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 8 directly disclosed connections are confirming.

What changed
  • Revenue increased 2.0% versus the comparable filing period.
Company+1.9% todayVolume comparison unavailable
Market group0 of 1 activePlasma-Derived Biologics · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • Six-month interest expense increased with higher average debt balances under ADMA’s senior secured credit facility.

Invalidation: The isolated read changes if ADMA's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind ADMA

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

JPMJP Morgan Chase & Co.lenderMay 6, 2026

JPM Credit Agreement On August 5, 2025 (the “JPM Closing Date”), we entered into a Credit Agreement (the “JPM Credit Agreement”) with the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent.

GRFSFiling-linked namecompetitorFeb 25, 2026

In December 2018, our former contract manufacturer assigned its rights and obligations under the 2011 Plasma Purchase Agreement to Grifols Worldwide Operations Limited (“Grifols”) as its successor-in-interest, effective January 2019.

Depended on by

HTGCHercules Capital, Inc.investeeOct 30, 2025

Our gains were offset by gross realized losses of $3.3 million and $15.0 million, respectively, for the three and nine month periods, from the write-off of equity and warrant investments in Proterra, Inc., The Faction Group LLC, Udacity, Inc., Humanigen, Inc.…

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

ADMA is currently a Leader in the organic co-movement group Plasma-Derived Biologics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for ADMA; it is not active in the latest market snapshot.